News
SHPMF
1.530
NaN%
--
Shanghai Pharmaceuticals Renews 2026 Supply Framework with Major Shareholder Yunnan Baiyao
TipRanks · 48m ago
Shanghai Pharmaceuticals Announces Interim Dividend for 2025
TipRanks · 12/10 09:15
Shanghai Pharmaceuticals Strengthens Audit Committee Governance
TipRanks · 12/09 10:40
Shanghai Pharmaceuticals Announces Key Changes at Extraordinary General Meeting
TipRanks · 12/09 10:08
Shanghai Pharmaceuticals Announces Extraordinary General Meeting
TipRanks · 11/28 09:10
Shanghai Pharmaceuticals Announces Interim Dividend for 2025
TipRanks · 11/18 09:11
Shanghai Pharmaceuticals Announces EGM to Revamp Governance Structure
TipRanks · 11/18 08:38
HSBC Remains a Sell on Shanghai Pharmaceuticals Holding Co (SHPMF)
TipRanks · 11/13 00:37
Shanghai Pharmaceuticals Proposes Governance Restructuring
TipRanks · 11/06 09:39
Citi Sticks to Their Buy Rating for Shanghai Pharmaceuticals Holding Co (SHPMF)
TipRanks · 11/06 00:38
Shanghai Pharmaceuticals Releases 2025 Q3 Report Emphasizing Transparency
TipRanks · 10/30 10:55
Shanghai Pharmaceuticals Announces 2025 Interim Profit Distribution Plan
TipRanks · 10/30 10:11
Shanghai Pharmaceuticals Announces Interim Dividend for 2025
TipRanks · 10/30 10:10
Shanghai Pharmaceuticals Advances Breast Cancer Treatment Study with SPH4336
TipRanks · 10/27 19:56
Shanghai Pharmaceuticals’ Promising Phase II Study on Breast Cancer Brain Metastases
TipRanks · 10/27 19:56
Shanghai Pharmaceuticals’ SPH7854 Study: A Potential Game-Changer for Inflammatory Bowel Disease?
TipRanks · 10/27 19:55
Shanghai Pharmaceuticals’ SPH7485: A Promising Step in Cancer Treatment
TipRanks · 10/27 19:55
Shanghai Pharmaceuticals’ Promising Breast Cancer Study: Key Insights for Investors
TipRanks · 10/27 19:55
Shanghai Pharmaceuticals’ T3011 Study: A Potential Game-Changer in Melanoma Treatment
TipRanks · 10/27 17:47
More
Webull provides a variety of real-time SHPMF stock news. You can receive the latest news about Shanghai Pharmaceuticals Hldg through multiple platforms. This information may help you make smarter investment decisions.
About SHPMF
Shanghai Pharmaceuticals Holding Co Ltd is a China-based company mainly engaged in pharmaceutical distribution business. The Company mainly operates four business segments. The Industrial segment is mainly engaged in the research and development, production, and sales of drugs and health products. The Distribution segment is mainly engaged in providing distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and distributors. The Retail segment is mainly engaged in operating and franchising the retail pharmacy network. The Others segment mainly engage in other businesses. The Company mainly operates its businesses in the domestic market.